Trial Profile
Post-marketing surveillance study on long-term use of MIRCERA in CKD patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2016
Price :
$35
*
At a glance
- Drugs Methoxy polyethylene glycol-epoetin beta (Primary)
- Indications Anaemia
- Focus Adverse reactions
- Sponsors Chugai Pharmaceutical
- 03 Oct 2016 New trial record